Lipodermatosclerosis secondary to pemetrexed use

J Thorac Oncol. 2015 Mar;10(3):e11-2. doi: 10.1097/JTO.0000000000000426.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Dermatitis / pathology
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Pemetrexed / adverse effects*
  • Prognosis
  • Scleroderma, Localized / chemically induced*
  • Scleroderma, Localized / pathology

Substances

  • Antineoplastic Agents
  • Pemetrexed

Supplementary concepts

  • Lipodermatosclerosis